Latest Articles

Article Type

You have access
Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
Robert N. Willette, Parth Mangrolia, Stephen M Pondell, Christopher Young Woo Lee, Sanghee Yoo, Marc S Rudoltz, Benjamin R Cowen and Dean J Welsch

Journal of Pharmacology and Experimental Therapeutics October 1, 2021, JPET-AR-2021-000811; DOI: https://doi.org/10.1124/jpet.121.000811
You have access
Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide Following Growth Hormone-Releasing Hormone Stimulation
Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce and Tomoya Ohno

Journal of Pharmacology and Experimental Therapeutics October 1, 2021, JPET-AR-2021-000769; DOI: https://doi.org/10.1124/jpet.121.000769
You have access
Therapeutic Effects of Time-limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat
Clifford L Eastman, Jason S Fender, Pavel Klein and Raimondo D'Ambrosio

Journal of Pharmacology and Experimental Therapeutics September 30, 2021, JPET-AR-2021-000585; DOI: https://doi.org/10.1124/jpet.121.000585
You have access
Selective Inhibition of NMDA receptors with GluN2B subunit protects beta cells against stress-induced apoptotic cell death
Anne Gresch, Héctor Noguera Hurtado, Laura Wörmeyer, Vivien De Luca, Rebekka Wiggers, Guiscard Seebohm, Bernhard Wünsch and Martina Düfer

Journal of Pharmacology and Experimental Therapeutics September 30, 2021, JPET-AR-2021-000807; DOI: https://doi.org/10.1124/jpet.121.000807
You have access
Caspase-8 regulates the anti-myeloma activity of bortezomib and lenalidomide
LIANG ZHOU, Xiangao Huang, Ruben Niesvizky, Zhongjian Pu and Guoqiang Xu

Journal of Pharmacology and Experimental Therapeutics September 29, 2021, JPET-AR-2021-000818; DOI: https://doi.org/10.1124/jpet.121.000818
You have access
Enhancing Target Tissue Levels and Diminishing Plasma Clearance of Ionizing Zwitterionic Antidotes in Organophosphate Exposures
Yan-Jye Shyong, Yadira Sepulveda, Arnold Garcia, Nathan M. Samskey, Zoran Radic, Rakesh K. Sit, K. Barry Sharpless, Jeremiah D. Momper and Palmer Taylor

Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 315-321; DOI: https://doi.org/10.1124/jpet.121.000715
You have access
Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”
Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 322; DOI: https://doi.org/10.1124/jpet.121.000525err
You have access
Brain distribution of berzosertib: an ATR inhibitor for the treatment of glioblastoma
Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S Mohammad, Sonja Dragojevic, Shiv K. Gupta, Ranjit S. Bindra, Jann N. Sarkaria and William F. Elmquist

Journal of Pharmacology and Experimental Therapeutics September 23, 2021, JPET-AR-2021-000845; DOI: https://doi.org/10.1124/jpet.121.000845
You have access
Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents, J Pharmacol Exp Ther, 344: 141-154; DOI: https://doi.org/10.1124/jpet.112.199497
Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 313; DOI: https://doi.org/10.1124/jpet.112.199497concern
You have access
Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW (2014) The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System, J Pharmacol Exp Ther, 351: 390-402; DOI: https://doi.org/10.1124/jpet.114.218735
Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 311; DOI: https://doi.org/10.1124/jpet.114.218735concern

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals